You can help heal people suffering from PTSD by making a gift toward the production of MDMA needed for U.S. Food and Drug Administration (FDA) Phase 3 clinical trials of MDMA-assisted psychotherapy. To …
November marked the start of what we anticipate will be our final fundraising campaign to raise the remaining $170,000 of the $400,000 required for the purchase of one kilogram of GMP MDMA to be used in …
For the fifth consecutive year, the Zendo Project will provide psychedelic harm reduction services at Envision Festival in Costa Rica, an event taking place in February 2017. Last year at Envision Festival, …
The Journal of Psychedelic Studies is currently accepting manuscript submissions for upcoming publications. The journal seeks to provide an interdisciplinary forum for the exchange of information about …
The Ketamine Papers Edited by Phil Wolfson, M.D., and Glenn Hartelius, Ph.D. Paperback | 448 pages | Published by MAPS The Ketamine Papers opens the door to a broad understanding of this medicine’s …
Ayahuasca Reader Edited by Luis Eduardo Luna and Steven F. White Paperback | 496 pages | Synergetic Press The new, expanded edition ofAyahuasca Readershares many distinct voices of the global ayahuasca …
The California Institute of Integral Studies (CIIS) is enrolling applicants for the Psychedelic-Assisted Therapies and Research Certificate program taking place in San Francisco, Calif. Learn more…
MAPS Public Benefit Corporation (MPBC), a wholly owned subsidiary of MAPS, is currently hiring a Clinical Operations Associate (COA) to work from our office in Santa Cruz, Calif., and support the MPBC …
In October 2016, MAPS received nearly $372,000 in new donations and pledges from 313 supporters. In the month of October, MAPS held its annual New York City fundraising dinner, the Future of Psychedelic …
The Shulgin Archive is dedicated to creating a global-access digital library of psychedelic research pioneer Alexander “Sasha” Shulgin and his wife Ann Shulgin’s extensive documentation …
From October 16-22, 2016, 25 trainees gathered in in Stony Point, New York, to participate in Part B of the MDMA Therapy Training Program. The five-part training program is currently preparing therapy …